Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome - a randomized placebo-controlled clinical trial.
- 2025-03-26
- RCT
- BMC complementary medicine and therapies 25(1)
- Arezoo Maleki-Hajiagha
- Faraz Mojab
- Fardin Amidi
- Leila Amini
- PubMed: 40141012
- DOI: 10.1186/s12906-025-04858-2
- High evidence
- Clinical
The study found a significantly lower triglyceride levels and malondialdehyde after eight weeks of S. officinalis extract intake compared to placebo.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 330 mg daily